Regulatory issues in cord blood banking and transplantation

Best Practice and Research: Clinical Haematology

Volumn 23, Issue 2, 2010, Pages 171-177

  Wall, Donna A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

accreditation; cord blood banking; cord blood transplantation; regulatory

Indexed keywords

CD34 ANTIGEN; DNA; GROWTH FACTOR; HLA ANTIGEN;

ACCREDITATION; ADULT; BLOOD BANK; BLOODBORNE BACTERIUM; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL LOSS; CELL THERAPY; CELL VIABILITY; COLONY FORMING UNIT; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; EGG; EMBRYO; EUROPE; FAMILY HISTORY; FOOD AND DRUG ADMINISTRATION; FREEZING; GRAFT FAILURE; HEALTH CARE ORGANIZATION; HEMATOLOGIC DISEASE; HEMOGLOBINOPATHY; HLA TYPING; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRESERVATION; PRIORITY JOURNAL; PROCESSING; QUALITY CONTROL; QUESTIONNAIRE; REGULATORY MECHANISM; REVIEW; RISK; SCREENING; SICKLE CELL ANEMIA; SPERM; STANDARD; THALASSEMIA; TRAFFIC AND TRANSPORT; UMBILICAL CORD BLOOD; UNITED STATES;

BLOOD BANKS; BLOOD PRESERVATION; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HUMANS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956600148     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2010.05.006     Document Type: Review

References (20)

1. L.M. Foeken, A. Green, and C.K. Hurley Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports Bone Marrow Transplant 2010
2. Code of Federal Regulations.21 CFR 600.3(s).
3. A. Brand, H. Eichler, and Z.M. Szczepiorkowski Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise Transfusion 48 3 2008 546 549
4. FDA. Draft guidance for industry: potency tests for cellular and gene therapy products. 2008.
5. V. Rocha, and E. Gluckman Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors Br J Haematol 147 2 2009 262 274
6. V. Rocha, M. Labopin, and G. Sanz Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia N Engl J Med 351 22 2004 2276 2285
7. A. Scaradavou, K.M. Smith, and R. Hawke Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation Biol Blood Marrow Transplant 2009
8. A.R. Migliaccio, J.W. Adamson, and C.E. Stevens Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity Blood 96 8 2000 2717 2722
9. J. McCullough, D. McKenna, and D. Kadidlo Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center Blood 114 8 2009 1684 1688
10. J. McCullough, D. McKenna, and D. Kadidlo Issues in the quality of umbilical cord blood stem cells for transplantation Transfusion 45 6 2005 832 841
11. P. Solves, D. Planelles, and V. Mirabet Utility of bag segment and cryovial samples for quality control and confirmatory HLA typing in umbilical cord blood banking Clin Lab Haematol 26 6 2004 413 418
12. H.S. Goodwin, L.M. Grunzinger, and D.M. Regan Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential Cytotherapy 5 1 2003 80 86
13. NetCord-FACT international standards for cord blood collection B, and release for administration. 4th ed. 2010.
14. H.E. Broxmeyer, E.F. Srour, and G. Hangoc High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years Proc Natl Acad Sci U S A 100 2 2003 645 650
15. P.I. Warkentin Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT) Cytotherapy 5 4 2003 299 305
16. Foundation for Accreditation of Cellular Therapies: FACTwebsite.org.
17. C.K. Hurley, and C. Raffoux World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries Bone Marrow Transplant 34 2 2004 103 110
18. C.K. Hurley, L. Foeken, and M. Horowitz Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products Bone Marrow Transplant 2010
19. FDA. Draft guidance for industry: minimally manipulated, unrelated allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution for specified indications. 2009.
20. FDA. Draft guidance for industry and FDA staff investigational new drug applications (INDs) for minimally manipulated, unrelated allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution for specified indications. 2009.